2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
1
Neoplasms
1
Constipation
1
Cancer Pain
1
Interventions
Fentanyl
27
Analgesia
23
Morphine
20
Acupuncture Therapy
18
Surveys and Questionnaires
16
Oxycodone
16
Zoledronic Acid
15
Acetaminophen
14
Therapeutics
13
Radiotherapy
13
Psychiatric Rehabilitation
13
Ketamine
13
Methadone
11
Lidocaine
11
Hydromorphone
11
Bupivacaine
11
nabiximols
10
Ibandronic Acid
10
Ropivacaine
9
Early Intervention, Educational
7
Analgesics, Opioid
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
oxycodone naloxone combination
×
Clear all
NCT01014559
2015-09-28
OXN3505
Mundipharma SAS
Phase 3
Terminated
225 enrolled